More than glycemic control: SGLT2 inhibitors may extend lung cancer survival
A retrospective study offers hope
#213 ‒ Liquid biopsies and cancer detection | Max Diehn, M.D. Ph.D.
“I was frustrated by not being able to diagnose a recurrence earlier.” —Max Diehn
Are “safe” levels of air pollution really safe?
Current evidence, and what to do about it
A broader perspective on lung cancer
Not just a “smoker’s disease”